Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
2021 ASCO Quality Care Symposium
ESMO Congress 2021
SOHO 2021
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Expert���s Corner
Advertisement
Advertisement
Oct
19
Today In Oncology
Second-Line Sotorasib Plus Afatinib for KRAS–Mutant NSCLC
DM-CHOC-PEN May Improve Outcomes for Adolescents and Young Adults With Central Nervous System Tumors
Can Inhibition of the Aurora Kinase A Protein Help to Overcome Resistance to KRAS Inhibition in Patients With Lung Cancer
FDA Perspective on Drug-Dosing in Oncology From More Is Better to Less Can Be More
Abiraterone for Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer
View More
Advertisement
